CDAS classification scheme and proportion of CIDP patients within each category

	Patients (n = 106)
1. Cure: ≥5 years off treatment	11% cure
A. Normal examination	6 (6%)
B. Abnormal examination, stable/improving	5 (5%)
2. Remission: <5 years off treatment	20% remission
A. Normal examination	12 (11%)
B. Abnormal examination, stable/improving	10 (9%)
3. Stable active disease: ≥1 year, on treatment	44% stable disease
A. Normal examination	18 (17%)
B. Abnormal examination, stable/improving	29 (27%)
4. Improvement: ≥3 months <1 year, on treatment	7% improving
A. Normal examination	0 (0%)
B. Abnormal examination, stable/improving	8 (7%)
5. Unstable active disease: Abnormal examination with progressive or relapsing course*	18% active disease
A. Treatment naïve or <3 months	6 (6%)
B. Off treatment	7 (7%)
C. On treatment	5 (5%)

The classification is based upon the clinical assessment of the treating physician at the time of last evaluation.

CIDP: chronic inflammatory demyelinating polyneuropathy; CDAS: CIDP Disease Activity Status.
* 5B and 5C refer to patients who were treatment refractory from prior therapy or worsening despite ongoing therapy.

From: Gorson KC, van Schaik IN, Merkies IS, et al. Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice. J Peripher Nerv Syst 2010; 15:326. DOI: 10.1111/j.1529-8027.2010.00284.x. Copyright © 2010 Peripheral Nerve Society. Reproduced with permission of John Wiley & Sons Inc. This image has been provided by or is owned by Wiley. Further permission is needed before it can be downloaded to PowerPoint, printed, shared or emailed. Please contact Wiley's permissions department either via email: [email protected] or use the RightsLink service by clicking on the 'Request Permission' link accompanying this article on Wiley Online Library (http://onlinelibrary.wiley.com).

Graphic 104439 Version 1.0

خرید پکیج

CDAS classification scheme and proportion of CIDP patients within each category